Both in Pharmaceuticals
Agios Pharmaceuticals vs Generate Biomedicines
Over the past year AGIO returned −6.6% and GENB returned −9.9%; their daily moves had a correlation of 0.51.
AGIO −6.6% GENB −9.9%Growth of $1, one year, split-adjusted
| Metric | AGIO | GENB |
|---|---|---|
| Price | $31.38 | $14.16 |
| Market cap | $1.87B | $1.82B |
| Today | +0.58% | +2.24% |
| 1 month | −1.1% | +2.6% |
| 6 months | +16.3% | — |
| Year to date | +15.3% | — |
| 1 year | −21.8% | — |
| Revenue growth (YoY) | +259.3% | — |
| Gross margin | 93.3% | 100.0% |
| Net margin | −225.1% | −1065.2% |
| P/E (TTM) | — | — |
| Price / sales | 19.1× | — |
| Net cash | $617.6M | $452.3M |
| Dividend yield | — | — |
| Volatility (60d) | 58.0% | — |
| Short % of float | 12.2% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).